Synpromics Announce Research Partnership with Solid Biosciences

Leaders in gene control, Synpromics have announced their new research partnership with Solid Biosciences LLC. The partnership will focus on research around developing treatment options for Duchenne muscular dystrophy (DMD). DMD is a muscle-wasting disease that is progressive, irreversible and ultimately fatal. Currently there is no cure and unsatisfactory treatments for patients. The research aims to advance Solid Biosciences AAV muscle-directed gene therapy research programme....

Ingenza Invests in Fast Fermentation Development

Ingenza, a leading industrial biotechnology company has acquired a system to enable faster development of new fermentation process. By accelerating development timelines, the Satorius ambr 250 modular system is compact allowing it to fit into laboratory fermentation workflows. To read the full article, click here.

Strathclyde spinout raises £461,000 in investment round

3f bio Ltd, a spinout company from the University of Strathclyde has secured an investment round of £461,000. 3f bio Ltd is involved in the sustainable production of food protein, at a reduced cost. The funding raised allows 3f bio Ltd to progress development of the product and increasing scale of production, as well as embarking on technological advances to global potentials for sustainable protein....